NLS Pharmaceutics AG (NLSP)

Oct 30, 2025 - NLSP was delisted (reason: merged into NCEL)

0.7620

+0.0220 (2.97%)

Inactive · Last trade price on Oct 30, 2025

NLS Pharmaceutics AG Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Income	-3.36	-3.64	-11.81	-15.48	-11.86	-2.3
Net Income	-6.21	-4.06	-12.17	-16.5	-11.95	-2.86
Earnings Per Share	-2.06	-2.63	-12.75	-33.52	-40.15	-16.45
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Investments	3.07	1.67	0.9	8.95	5.43	0.09
Total Debt	-	-	1.63	-	-	2.08
Net Cash (Debt)	3.07	1.67	-0.74	8.95	5.43	-1.99
Net Cash Growth	84.48%	-	-	64.76%	-	-
Net Cash Per Share	1.02	1.08	-0.77	18.19	18.25	-11.44

Cash Flow & CapEx

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Cash Flow	-4.81	-4.27	-9.68	-13.88	-14.94	-0.73
Capital Expenditures	-0	-0	-	-	-0.04	-
Free Cash Flow	-4.82	-4.27	-9.68	-13.88	-14.98	-0.73
Free Cash Flow Growth	-	-	-	-	-	-